The Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that has been shown to act as ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

Kennedy said that removing all 17 members of the CDC's vaccine advisory panel was "necessary to reestablish public confidence ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could ...

It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.